Burning Rock Biotech Limited (BNR)

NASDAQ: BNR · Real-Time Price · USD

15.99

-1.64 (-9.30%)

At close: Oct 1, 2026, 4:00 PM EDT

16.03

+0.04 (0.25%)

After-hours: Oct 1, 2026, 7:30 PM EDT

Burning Rock Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	500.64	539.57	515.82	537.44	563.24	507.86
Revenue Growth	-6.65%	4.60%	-4.02%	-4.58%	10.90%	18.13%
Cost of Revenue	127.41	136.65	153.42	174.21	183.2	143.72
Gross Profit	373.23	402.91	362.4	363.23	380.04	364.15
Selling, General & Admin	303.12	291.27	452.54	685.53	938.58	793.35
Research & Development	135.12	166.49	232.29	347.02	421.87	367.86
Operating Expenses	438.25	457.76	684.83	1,033	1,360	1,161
Operating Income	-65.02	-54.85	-322.43	-669.32	-980.41	-797.06
Interest Expense	-0.06	-0.03	-	-	-	-1.54
Interest & Investment Income	5.88	8.05	12.21	17.96	9.36	3.46
Currency Exchange Gain (Loss)	-7.32	-6.71	-0.1	-0.42	1.55	-0.85
Other Non Operating Income (Expenses)	0.1	-0.26	4.71	0.48	0.25	0.2
EBT Excluding Unusual Items	-66.42	-53.79	-305.61	-651.3	-969.25	-795.8
Asset Writedown	-	-	-35.13	-	-	-
Pretax Income	-66.42	-53.79	-340.74	-651.3	-969.25	-795.8
Income Tax Expense	1.61	1.56	5.89	2.39	1.99	0.9
Net Income	-68.03	-55.35	-346.63	-653.69	-971.23	-796.7
Net Income to Common	-68.03	-55.35	-346.63	-653.69	-971.23	-796.7
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	11	11	10	10	10	10
Shares Outstanding (Diluted)	11	11	10	10	10	10
Shares Change	0.43%	3.27%	0.53%	-1.46%	-0.29%	51.83%
EPS (Basic)	-6.42	-5.21	-33.67	-63.84	-93.47	-76.45
EPS (Diluted)	-6.42	-5.21	-33.67	-63.84	-93.47	-76.45
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-17.47	-33.69	-97.68	-263.89	-527.1	-688.81
Free Cash Flow Per Share	-1.65	-3.17	-9.49	-25.77	-50.73	-66.10
Gross Margin	74.55%	74.67%	70.26%	67.58%	67.47%	71.70%
Operating Margin	-12.99%	-10.17%	-62.51%	-124.54%	-174.07%	-156.94%
Profit Margin	-13.59%	-10.26%	-67.20%	-121.63%	-172.44%	-156.87%
Free Cash Flow Margin	-3.49%	-6.24%	-18.94%	-49.10%	-93.58%	-135.63%
EBITDA	-58.27	-33.22	-271.05	-537.87	-859.66	-752.46
EBITDA Margin	-11.64%	-6.16%	-52.55%	-100.08%	-152.63%	-148.16%
D&A For EBITDA	6.74	21.62	51.39	131.45	120.75	44.6
EBIT	-65.02	-54.85	-322.43	-669.32	-980.41	-797.06
EBIT Margin	-12.99%	-10.17%	-62.51%	-124.54%	-174.07%	-156.94%
Revenue as Reported	539.57	539.57	515.82	537.44	563.24	507.86

SEC Filings: 10-K · 10-Q